Tech Company Financing Transactions

Colossal Biosciences Funding Round

Colossal Biosciences closed a $200 million Series C financing round on 1/15/2025. Investors included Animal Capital, At One Ventures and Bold Capital Partners.

Transaction Overview

Company Name
Colossal Biosciences
Announced On
1/15/2025
Transaction Type
Venture Equity
Amount
$200,000,000
Round
Series C
Investors

Animal Capital

At One Ventures

Bold Capital Partners

Breyer Capital

Draper Associates

In-Q-Tel

private investors (Brandon Fugal)

private investors (Fran Walsh)

private investors (Giammaria Giuliani)

private investors (Jeff Wilke)

private investors (Paul Jones)

private investors (Peter Jackson)

private investors (Ric Edelman)

private investors (Richard Garriott)

private investors (Robert Nelsen)

private investors (Sven-Olof Lindblad)

private investors (Victor Vescovo)

Peak6

Proceeds Purpose
The company intends to use the funds to continue to advance its genetic engineering technologies while pioneering new software, wetware and hardware solutions, which have applications beyond de-extinction including species preservation and human healthcare.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Dallas, TX Undisclosed
USA
Phone
Undisclosed
Website
www.colossal.com
Email Address
Not Recorded
Overview
At Colossal Biosciences, we endeavor to jumpstart nature's ancestral heartbeat. To see the Woolly Mammoth thunder upon the tundra once again. To advance the economies of biology and nutrition. To make humanity more human. And to reawaken the lost wilds of Earth. So we, and our planet, can breathe easier.
Profile
Colossal Biosciences LinkedIn Company Profile
Social Media
Colossal Biosciences Company Twitter Account
Company News
Colossal Biosciences News
Facebook
Colossal Biosciences on Facebook
YouTube
Colossal Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Operating Officer
Kent Wakeford
  Kent Wakeford LinkedIn Profile  Kent Wakeford Twitter Account  Kent Wakeford News  Kent Wakeford on Facebook
Co-Founder
Brian Beard
  Brian Beard LinkedIn Profile  Brian Beard Twitter Account  Brian Beard News  Brian Beard on Facebook
Co-Founder
Andrew Busey
  Andrew Busey LinkedIn Profile  Andrew Busey Twitter Account  Andrew Busey News  Andrew Busey on Facebook
Co-Founder
Peter Phillips
  Peter Phillips LinkedIn Profile  Peter Phillips Twitter Account  Peter Phillips News  Peter Phillips on Facebook
Founder
George Church
  George Church LinkedIn Profile  George Church Twitter Account  George Church News  George Church on Facebook
Founder
Ben Lamm
  Ben Lamm LinkedIn Profile  Ben Lamm Twitter Account  Ben Lamm News  Ben Lamm on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/15/2025: Brickken venture capital transaction
Next: 1/15/2025: Maki venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2025. Gaebler Ventures. All rights reserved.